820 Dubuque Avenue
South San Francisco
8 articles about Mirvie Inc
Mirvie Becomes First RNA-Based Pregnancy Health-Focused Company to Receive Clinical Laboratory Improvement Amendments (CLIA) Certification
Mirvie has been certified by the Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity clinical testing.
Mirvie Receives $4.6 Million Grant to Study Objective Prediction of Preeclampsia in Sub-Saharan Africa
Mirvie announced a $4.6 million grant from the Bill & Melinda Gates Foundation to support the company’s efforts to predict unexpected pregnancy complications before they happen by revealing the underlying biology of each pregnancy for women on a global scale.
First Comprehensive Care Plan to Prevent Preeclampsia Published in the American Journal of Obstetrics and Gynecology
A new special report published in the American Journal of Obstetrics and Gynecology provides a groundbreaking approach to preeclampsia, one of the most pressing issues in maternal health and will translate the prediction of risk into prevention of disease.
Mirvie, a pioneer in predicting unexpected pregnancy complications, announced the appointment of Alison Cowan, M.D., M.S.C.R. as Head of Medical Affairs.
Recent funding saw support for a platform that selectively degrades DNA, software to help read mammograms and a company using corn genetics to develop cancer-targeting viruses.
Mirvie, a pioneer in predicting unexpected pregnancy complications, announced it has raised a total of $90 million to date following the close of its Series B funding.
Late-breaking Data Presented at SMFM 2022 Annual Meeting Shows The Mirvie RNA Platform is First to Reveal The Underlying Biology of Preterm Birth
Mirvie, a pioneer in predicting unexpected pregnancy complications, announced data presented at the Society for Maternal-Fetal Medicine 42nd Annual Pregnancy Meeting demonstrates the Mirvie RNA platform is first to predict preterm birth by revealing the underlying biology of each pregnancy.
Study Published in Nature Shows Mirvie Can Predict Pregnancy Complications Months Before They Happen Using New, Proprietary RNA Platform
Mirvie, a pioneer in predicting unexpected pregnancy complications, today announced the publication of a study in Nature proving the proprietary Mirvie RNA platform is first to predict unexpected complications by revealing the underlying biology of each pregnancy.